Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements have led to a more efficient and personalized approach to treatment. Andrew Wilson, President of Oncology Informatics at Elekta, discussed the latest advancements in analytical software with ITN.
itnTV
Talking Trends with Elekta
Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements have led to a more efficient and personalized approach to treatment. Andrew Wilson, President of Oncology Informatics at Elekta, discussed the latest advancements in analytical software with ITN.
Recent Videos View all 577 items
Konica Minolta’s theme for RSNA 2020 is Depth of Vision. ITN recently talked with David Widmann, President and CEO of Konica Minolta Healthcare Americas, about this focus and their key messages for customers and RSNA attendees.
Agfa is looking to transform X-ray with new advancements in volumetric imaging, and with new mobile concepts and implementation of intelligent tools. ITN had a conversation with Georges Espada on Transforming X-ray with Intelligent Tools.
Fujifilm's next generation secure server-side viewer platform extends across enterprise imaging areas to bring together radiology, mammography and cardiology into a single zero footprint platform. Bill Lacy, vice president of medical informatics for Fujifilm Medical Systems USA recently talked with ITN about their Synapse 7x platform.
Sponsored Videos View all 159 items
Kevin Borden, Vice President of Product, Healthcare IT for Konica Minolta, talks about Improving Access and Aiding Workflow with itnTV. He explains how the server-side rendering and zero-footprint viewer in its Exa PACS make it well-suited for remote reading.
At this year’s RSNA ITN sat down with Dennis Durmis, Senior Vice President, Bayer Radiology to discuss Radiology trends. Discussion topics centered around three key areas where Bayer Radiology is responding to trends; including digitalization, workflow efficiencies and efforts to bring more focus to the Radiology patient experience. During the interview Dennis discussed Bayer’s digital strategy, features and benefits of their new injector, the MEDRAD® Stellant FLEX Injector and Bayer’s education efforts of the imaging needs of women with Dense Breast.
At RSNA19, Philips discussed with ITN Contributing Editor Greg Freiherr how its IntelliSpace Enterprise Edition fits into the Philips portfolio, and how the corporate acquisition of Carestream Health IT might affect the company. The video also discusses how Philips will help prospective customers acquire its products.
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence (AI) advances at the Radiological Society of North America (RSNA) 2019 annual meeting.
Technology Reports View all 11 items
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence (AI) advances at the Radiological Society of North America (RSNA) 2019 annual meeting.
In Enterprise Imaging at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of enterprise imaging advances at the Radiological Society of North America (RSNA) 2019 annual meeting.
In Artificial Intelligence 2018: What Radiologists Need to Know About AI, ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence (AI) advances at the Radiological Society of North America (RSNA) 2018 annual meeting.
Related Artificial Intelligence Content
Technology Report: Artificial Intelligence 2017
VIDEO: RSNA Post-game Report on Artificial Intelligence
VIDEO: AI in Tumor Diagnostics, Treatment and Follow-up
VIDEO: Artificial Intelligence May Help Reduce Gadolinium Dose in MRI
In Enterprise Imaging 2018: Balancing Strategy and Technology in Enterprise Imaging, ITN Contributing Editor Greg Freiherr offers an overview of enterprise imaging advances at the Radiological Society of North America (RSNA) 2018 annual meeting.
Related Enterprise Imaging Content:
RSNA Technology Report 2017: Enterprise Imaging
VIDEO: Building An Effective Enterprise Imaging Strategy
Five Steps for Better Diagnostic Image Management
VIDEO: Enterprise Imaging and the Digital Imaging Adoption Model
Enterprise Imaging to Account for 27 Percent of Imaging Market
VIDEO: Defining Enterprise Imaging — The HIMSS-SIIM Enterprise Imaging Workgroup
Conference Coverage View all 465 items
Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements have led to a more efficient and personalized approach to treatment. Andrew Wilson, President of Oncology Informatics at Elekta, discussed the latest advancements in analytical software with ITN.
Konica Minolta’s theme for RSNA 2020 is Depth of Vision. ITN recently talked with David Widmann, President and CEO of Konica Minolta Healthcare Americas, about this focus and their key messages for customers and RSNA attendees.
Agfa is looking to transform X-ray with new advancements in volumetric imaging, and with new mobile concepts and implementation of intelligent tools. ITN had a conversation with Georges Espada on Transforming X-ray with Intelligent Tools.
Fujifilm's next generation secure server-side viewer platform extends across enterprise imaging areas to bring together radiology, mammography and cardiology into a single zero footprint platform. Bill Lacy, vice president of medical informatics for Fujifilm Medical Systems USA recently talked with ITN about their Synapse 7x platform.
Radiation Oncology View all 116 items
Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements have led to a more efficient and personalized approach to treatment. Andrew Wilson, President of Oncology Informatics at Elekta, discussed the latest advancements in analytical software with ITN.
Bruce Bauer, Ph.D., CEO of TAE Life Sciences. The company is developing boron neutron capture therapy (BNCT) as a new radiation therapy for cancer. A patient is first infused with a non-toxic boron-10 compound, which selectively accumulates in tumor tissue. A neutron beam is then focused on the tumor and the neutrons are captured by the boron and causes emission of alpha radiation particles within the tumor. Alpha particles have a a very short range, so this helps spare surrounding healthy tissue from radiation damage.
Historically, BNCT clinical studies have been carried out using boronophenylalanine (BPA) and neutrons derived from the core of a nuclear reactor. While the clinical outcomes have been encouraging, the availability of better boron-10 compounds and access to a neutron source posed a significant barrier to clinical research and adoption of BNCT as a practical cancer therapy.
There is now a renaissance in BNCT with the availability of new accelerator-based neutrons sources and novel synthesis of boron-10 target drugs, allowing clinical research to expand with the goal to have BNCT available as a new treatment option for patients.
The secondary radiation reaction from BNCT, with cellular-level precision, spares more healthy tissues and can potentially treat cancers that otherwise have few treatment options.
The system requires a neutron accelerator, but this is smaller than a proton system and operates at much lower energy, so the shielding requirement is much lower, cutting construction costs.
Find more news and video on radiation therapy
At this year’s RSNA ITN sat down with Dennis Durmis, Senior Vice President, Bayer Radiology to discuss Radiology trends. Discussion topics centered around three key areas where Bayer Radiology is responding to trends; including digitalization, workflow efficiencies and efforts to bring more focus to the Radiology patient experience. During the interview Dennis discussed Bayer’s digital strategy, features and benefits of their new injector, the MEDRAD® Stellant FLEX Injector and Bayer’s education efforts of the imaging needs of women with Dense Breast.
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence (AI) advances at the Radiological Society of North America (RSNA) 2019 annual meeting.
Radiology Imaging View all 352 items
Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements have led to a more efficient and personalized approach to treatment. Andrew Wilson, President of Oncology Informatics at Elekta, discussed the latest advancements in analytical software with ITN.
Konica Minolta’s theme for RSNA 2020 is Depth of Vision. ITN recently talked with David Widmann, President and CEO of Konica Minolta Healthcare Americas, about this focus and their key messages for customers and RSNA attendees.
Agfa is looking to transform X-ray with new advancements in volumetric imaging, and with new mobile concepts and implementation of intelligent tools. ITN had a conversation with Georges Espada on Transforming X-ray with Intelligent Tools.
Fujifilm's next generation secure server-side viewer platform extends across enterprise imaging areas to bring together radiology, mammography and cardiology into a single zero footprint platform. Bill Lacy, vice president of medical informatics for Fujifilm Medical Systems USA recently talked with ITN about their Synapse 7x platform.
Molecular Imaging View all 28 items
Ernest Garcia, Ph.D., MASNC, FAHA, endowed professor in cardiac imaging, director of nuclear cardiology R&D laboratory, Emory University, developer of the Emory Cardiac Tool Box used in nuclear imaging and past-president of the American Society of Nuclear Cardiology (ASNC), explains the use of artificial intelligence (AI) in cardiac imaging. He said there is a tsunami of new AI applications that are starting to flood the FDA for market approval, and there are several examples of AI already in use in radiology. He spoke on this topic in a keynote session at the 2020 ASNC meeting.
Related Artificial Intelligence in Cardiology Content:
VIDEO: Machine Learning for Diagnosis and Risk Prediction in Nuclear Cardiology — Interview with Piotr J. Slomka, Ph.D.,
Artificial Intelligence Applications in Cardiology
VIDEO: Artificial Intelligence May Improve Cath Lab Interventions — Interview with Nick West, M.D., Abbott CMO
How Artificial Intelligence Will Change Medical Imaging
VIDEO: Artificial Intelligence for Echocardiography at Mass General — Interview with Judy Hung, M.D.
VIDEO: ACC Efforts to Advance Evidence-based Implementation of AI in Cardiovascular Care — Interview with John Rumsfeld, M.D.
VIDEO: Overview of Artificial Intelligence and its Use in Cardiology — Interview with Anthony Chang, M.D.
Stephen Bloom, M.D., FASNC, director of noninvasive cardiology (cardiac CT, nuclear cardiology and echocardiography) at Midwest Heart and Vascular Associates, Overland Park, Kansas. He is also a member of the American Society of Nuclear Cardiology (ASNC) Board of Directors, explains some of the issues involved and protocols used for cardiac imaging during the COVID-19 pandemic. His discussion includes computed tomography, cardiac ultrasound and nuclear imaging.
Right now, Bloom said it is difficult to test everybody and there is a shortage of masks, gowns and other personal protective equipment (PPE), and the imaging equipment needs to be sanitized each time it is used. He said it is just is not possible to image all the patients who need imaging right now. Hospitals also are trying to limit the number of healthy people people coming into hospitals for routine visits and tests to reduce their potential exposure to the novel coronavirus (COVID-19, SARS-CoV-2) and help containment efforts.
"The tests should be done, very simply, if it changes the care of the patient. If it doesn't change the care of the patient, and it can be postponed, it should be postponed," Bloom explained. "I would say 80 percent of our cardiac imaging exams have stopped. It has been very dramatic."
Related Imaging Precautions During COVID-19 Content:
Cardiac Imaging Best Practices During the COVID-19 Pandemic
Best Practices for Nuclear Cardiology Laboratories During the Coronavirus (COVID-19) Pandemic
ASE Guidelines for the Protection of Echocardiography Providers During the COVID-19 Outbreak
VIDEO: Best Practices for Nuclear Cardiology During the COVID-19 Pandemic — Interview with Hicham Skali, M.D.
VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak — Interview with Ehtisham Mahmud, M.D.
VIDEO: 9 Cardiologists Share COVID-19 Takeaways From Across the U.S.
VIDEO: Telemedicine in Cardiology and Medical Imaging During COVID-19 — Interview with Regina Druz, M.D.
VIDEO: Use of Teleradiology During the COVID-19 Pandemic — an interview with radiologist John Kim, M.D.
Study Looks at CT Findings of COVID-19 Through Recovery
Experts Stress Radiology Preparedness for COVID-19
VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS) — Interview with emergency physician Mike Stone, M.D.,
VIDEO: How China Leveraged Health IT to Combat COVID-19 — Interview with Jilan Liu, M.D., CEO for the HIMSS Greater China
ACR Recommendations for the Use of Chest Radiography and CT for Suspected COVID-19 Cases
VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.
Hicham Skali, M.D., a staff cardiologist and member of the Non-invasive Cardiovascular Imaging Program at Brigham and Women’s Hospital (BWH), and at Brigham and Women’s / Massachusetts General Health Care Center at Foxborough, explains the new recommendations from the American Society of Nuclear Cardiology (ASNC) and from imagers in China and Singapore. The ASNC created a best practices document for nuclear cardiology laboratories during the novel coronavirus (COVID-19, SARS-CoV-2) pandemic. The suggestions in the guidelines can ally to any imaging modality, including computed tomography (CT), MRI and ultrasound.
Skali elaborates on the following points in his discussion, which are specific recommendations in the ASNC and SNMMI COVID-19 guidance document:
• Rescheduling non-urgent visits
• Rescheduling elective surgeries and procedures
• Using separate spaces for patients with known or suspected COVID-19 to prevent spread
• Ensuring supplies are available
• Promoting use of telehealth
• Screen staff, patients and visitors before they enter the department
• Minimize non-essential visitors into the department
• Record symptoms at the start of the shift
• Use personal protective equipment (PPE)for healthcare personnel
• If available, use PPE for patients due to concern of asymptomatic transmission of COVID-19
• Maintain strict hand hygiene
• Maintain 6 feet distance in all patient/staff interactions when possible
• Work remotely whenever feasible, especially with ready studies
• Rotating staff schedules for on-site and off-site work
• Use of rest only studies if possible
• Use of half-time SPECT to speed exam times
• Use of PET if available to speed exam times
Skali served as the moderator in for the ASNC on demand webinar COVID-19 Preparedness for Nuclear Cardiology Labs: Insights from the US, China and Singapore.
VIDEO: Telemedicine in Cardiology and Medical Imaging During COVID-19 — Interview with Regina Druz, M.D., an ASNC Board member and also a speaker during the ASNC webinar.
Find more news and video on relating to COVID-19 and its impact on radiology
Regina Druz, M.D., FASNC, a member of the American Society of Nuclear Cardiology (ASNC) Board of Directors, chairwomen of the American College of Cardiology (ACC) Healthcare Innovation Section, and a cardiologist at Integrative Cardiology Center of Long Island, N.Y., explains the rapid expansion of telemedicine with the U.S. spread of novel coronavirus (COVID-19, SARS-CoV-2).
Druz spoke on the unprecedented expansion of telemedicine in the U.S. under COVID-19, seeing more use in the last two months, as opposed to the past two decades. The Centers for Medicare and Medicaid Services (CMS) previously only reimbursed for Telehealth in rural areas it determined had a shortage of doctors. However, in early March 2020, CMS dropped the geographic requirements and allowed Telehealth usage across th country as a way to mitigate person-to-person contact and keep vulnerable, older patients at home for routine check ups with doctors.
Druz has subspecialty certifications in nuclear cardiology, adult echocardiography and cardiac computed tomography (CT) and explains how Telehealth can be used to pre-screen patients and get patient sign off on procedures prior to coming in for an exam, helping speed the process in the hospital and limit personal contact.
Concerns about the rpaid spread of COVID-19 also has driven many radiology departments to convert to wider use of teleradiology to allow more radiologists to work from home and reduce person-to-person contact within the hospitals.
Watch the related VIDEO: Use of Teleradiology During the COVID-19 Pandemic — an interview with John Kim, M.D., chairman, Department of Radiology, THR Presbyterian Plano, Texas, and chief technology officer at Texas Radiology Associates.
Related COVID-19 Content:
VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS) — Interview with emergency physician Mike Stone, M.D.,
VIDEO: How China Leveraged Health IT to Combat COVID-19 — Interview with Jilan Liu, M.D., CEO for the HIMSS Greater China
Study Looks at CT Findings of COVID-19 Through Recovery
Experts Stress Radiology Preparedness for COVID-19
ACR Recommendations for the Use of Chest Radiography and CT for Suspected COVID-19 Cases
VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.
The Cardiac Implications of Novel Coronavirus
Information Technology View all 260 items
Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements have led to a more efficient and personalized approach to treatment. Andrew Wilson, President of Oncology Informatics at Elekta, discussed the latest advancements in analytical software with ITN.
Konica Minolta’s theme for RSNA 2020 is Depth of Vision. ITN recently talked with David Widmann, President and CEO of Konica Minolta Healthcare Americas, about this focus and their key messages for customers and RSNA attendees.
Agfa is looking to transform X-ray with new advancements in volumetric imaging, and with new mobile concepts and implementation of intelligent tools. ITN had a conversation with Georges Espada on Transforming X-ray with Intelligent Tools.
Fujifilm's next generation secure server-side viewer platform extends across enterprise imaging areas to bring together radiology, mammography and cardiology into a single zero footprint platform. Bill Lacy, vice president of medical informatics for Fujifilm Medical Systems USA recently talked with ITN about their Synapse 7x platform.
Women's Health View all 75 items
Artificial Intelligence (AI) is becoming more common place in radiology practices, and emerging technologies are providing radiologists with sophisticated detection software to aid their reading and provide support for a busy workflow. With the progression of AI technology, vendors must look not only at what AI can do for the radiologist, but how the radiologist and the technician interact with that technology – the goal should be increasing accuracy while also positively improving workflow. GE Healthcare is working to improve radiology AI workflow in its Centricity Universal Viewer.
Three key opinion leaders offers their views on what is needed to make AI more valauble and accessible to radiologists. These include:
• Amy Patel, M.D., breast radiologist, medical director, Liberty Hospital Women's Imaging, assistant professor of radiology, University of Missouri-Kansas City.
• Prof. Dr. Thomas Frauenfelder, M.D., vice chairman and professor of thoracic radiology, Institute for Diagnostic and Interventional Radiology, University of Zurich.
• Randy Hicks, M.D., chief executive officer, Regional Medical Imaging.
Learn more about the Centricity Universal Viewer in the VIDEO: How GE Healthcare’s Zero Footprint Remote Image Viewer Supports Clinical Care
Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, explains how breast magnetic resonance imaging (MRI) can be used to clearly identify breast cancers in women with dense breast tissue. In women with dense breasts, it can be very difficult to detect many cancers on standard mammograms because the cancers and dense tissue both appear white. MRI can help clearly define tumors and identify which nodules are cancer and which are benign, which can help greatly reduce the need for biopsies.
Kuhl is an expert in breast imaging and breast MRI. She helped develop an a shortened MRI protocol that allows breast MR images to be created in 3 minutes or less, rather than standard protocols that can take up to 30 minutes. In the interview she shows patient case examples of standard mammograms and the MRI supplemental imaging for the same patient to show the hidden tumors.
She also explains the differences between standard 2-d mammography, the current standard of care, and the newer 3-D mammogram tomosythnesis technology, breast ultrasound and breast MRI technologies.
Other video interviews with Dr. Kuhl:
VIDEO: Explaining Dense Breasts
VIDEO: The Impact of COVID-19 on Breast Imaging
Related Breast MRI Content:
Abbreviated MRI Outperforms 3-D Mammograms at Finding Cancer in Dense Breasts
VIDEO: Explaining Dense Breasts — Interview with Christiane Kuhl, M.D.
VIDEO: Use of Breast MRI Improved Cancer Detection in Dense Breasts in Dutch Study — Interview with Gillian Newstead, M.D.
Technologies to Watch in Breast Imaging
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
Rapid Breast MRI Screening Improves Cancer Detection in Dense Breasts
Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, explains how the COVID-19 (SARS-CoV-2) pandemic has impacted screening mammography and raised fears there will be a large increase in more advanced breast cancer cases in the near future as sizable numbers of women skip their annual exams this year. Kuhl also explains the COVID safety protocols most breast imaging centers are taking to limit any potential exposure to the virus from asymptomatic patients.
Other video interviews with Dr. Kuhl:
VIDEO: Explaining Dense Breasts
VIDEO: Use of Breast MRI Screening in Women With Dense Breasts
How COVID Has Disrupted Screening Mammography and The Urgency to Resume Screenings:
Breast Imaging in the Age of Coronavirus
Half of Breast Cancer Survivors Had Delays in Care Due to COVID-19
Insight on the Impact of COVID-19 on Medical Imaging
Delay in Breast Cancer Operations Appears Non Life-threatening for Early-stage Disease
Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, explains what it means to have dense breasts and how density can hide cancers in mammograms. She offers an explanation describing dense breast tissue and that this occurs in about half of women. Density is itself a risk factor for breast cancer and the fact that dense tissue hides cancers on mammography means that supplemental imaging is needed to accurately diagnose these patients and avoid false positives, or needless tissue biopsies. Breast ultrasound and breast magnetic resonance imaging (MRI) can be used to see through dense tissue to better identify cancers and avoid the need for many biopsies.
Other video interviews with Dr. Kuhl:
VIDEO: Use of Breast MRI Screening in Women With Dense Breasts
VIDEO: The Impact of COVID-19 on Breast Imaging
Related Dense Breast Content:
Animation to Bring Clarity to Dense Breasts
Improving Clinical Image Quality for Breast Imaging
Breast Imaging in the Age of Coronavirus
Abbreviated MRI Outperforms 3-D Mammograms at Finding Cancer in Dense Breasts
VIDEO: Use of Breast MRI Improved Cancer Detection in Dense Breasts in Dutch Study — Interview with Gillian Newstead, M.D.
Technologies to Watch in Breast Imaging
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients